Following the merger in March 2022, Fred Hutchinson Cancer Center is now an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research, and learning. Together, their fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality, a reality now supercharged by gifts from the Sloan Foundation and the Bezos family. Join us and choose to learn more about our new patient-supportive services, our continued leadership in the field of microbiome and viral research, our field-defining immunotherapy work, and the promise of precision oncology.
Dr. Amitabha (Uh-Myth-aabh) “Guppy” Gupta got his Ph.D. in Cellular, Molecular, and Biophysical Sciences from Columbia University before moving to the Fred Hutchinson Cancer Research Center to do his post-doctoral research. While he was doing his American Cancer Society-funded research and applying to be a teacher at a small liberal arts school, the Hutch convinced him to stay and talk about their research. He currently serves as the Scientific Content Strategist for the Philanthropy Department, where he keeps his finger on the pulse of the research going on at the Hutch and helps translate it to the general public.
Dr. Denise Buenrostro (Boo-en-rose-trow) was born and raised in Chula Vista, CA. She is a scientist, a cancer survivor, dance enthusiast and dog lover. After finishing her Ph.D. at Vanderbilt University’s Cancer Biology Program, she began a post-doctoral fellowship at Fred Hutch in Aude Chapuis’ lab in the Program in Immunology to study and improve immunotherapies. She has since transitioned into a role in Hutch’s philanthropy department with the hope of continuing to engage with external partners, particularly underserved communities.